Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The diagnosis value of promoter methylation of UCHL1 in the serum for progression of gastric cancer.

BioMed research international - 1 Jan 2015

Wang Gongping, Zhang Wei, Zhou Bo, Jin Canhui, Wang Zengfang, Yang Yantong, Wang Zhenzhen, Chen Ye, Feng Xiaoshan

Abstract excerpt

BACKGROUND: Aberrant promoter methylation has been considered as a potential molecular marker for gastric cancer (GC). However, the role of methylation of FLNC, THBS1, and UCHL1 in the development and progression of GC has not been explored. METHODS: The promoter methylation status of UCHL1, FLNC, THBS1, and DLEC1 was assessed by quantitative methylation-specific PCR (QMSP) in the serum of 82 GC patients, 46...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Progression
Share to DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Staging

Share to Prevalence

Share to Reproducibility of Results

Share to Sensitivity and Specificity

Share to Stomach Neoplasms

Share to Ubiquitin Thiolesterase

Source

Open in PubMed Open full text

Identifiers

PMID: 26550574
DOI: 10.1155/2015/741030
PMCID: PMC4624918

Genes

UCHL1
THBS1
FLNC
DLEC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The diagnosis value of promoter methylation of UCHL1 in the serum for progression of gastric cancer.PMID 26550574Read ↗

Epigenetic alterations of CYLD promoter modulate its expression in gastric adenocarcinoma: A footprint of infections.Semantic proximity Read ↗

CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) and P53 mutation pattern in sporadic colorectal cancer.Semantic proximity Read ↗

Role of DNA Methylation in the Development of Diffuse-Type Gastric CancerSemantic proximity Read ↗

E3 ubiquitin ligase RNF180 prevents excessive PCDH10 methylation to suppress the proliferation and metastasis of gastric cancer cells by promoting ubiquitination of DNMT1Semantic proximity Read ↗

Epigenetic identification of ubiquitin carboxyl‐terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors†Semantic proximity Read ↗

Helicobacter pylori CagA induces tumor suppressor gene hypermethylation by upregulating DNMT1 via AKT-NFκB pathway in gastric cancer developmentSemantic proximity Read ↗

The accumulation of DNA demethylation in Sat α in normal gastric tissues with Helicobacter pylori infection renders susceptibility to gastric cancer in some individuals.Semantic proximity Read ↗

Prediction of the risk for gastric cancer using candidate methylation markers in the non-neoplastic gastric mucosae.Semantic proximity Read ↗

Relationship between DLEC1 and PBX3 promoter methylation and the risk and prognosis of gastric cancer in peripheral blood leukocytes.Semantic proximity Read ↗

Clinical significance of the expression of DNA methyltransferase proteins in gastric cancerSemantic proximity Read ↗

Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers.Semantic proximity Read ↗

SFRP2 and RPRM as methylation based serum biomarkers for the detection of gastric cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.